Puerperal Disorders: Clinical Trials

7 trials for Puerperal Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Recruiting 7

Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brexanolone Lifting Outcomes Of Moms
LPCN 1154A, Placebo - Depression, Postpartum, Postpartum Depression (PPD)
Phase 3RecruitingLipocine Inc.1202026-09-012026-09-16
A Study of MI078 for Postpartum Depression
MI078 capsule, Placebo of MI078 capsules - Postpartum Depression (PPD)
Phase 3RecruitingNanjing Minova Pharmaceutical Co., Ltd.2002026-07-102026-07-23
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Aspirin, Low-molecular-weight heparin - Venous Thromboembolism, Postpartum Period
Phase 3RecruitingUniversity of Calgary88052026-06-042026-07-27
EVE TRIAL , ALMA SYSTAM
Alma System - Postpartum Haemorrhage (PPH), PPH
Phase 3RecruitingResQ Medical Ltd502026-01-112026-03-30
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Sublingual Misoprostol, IV Oxytocin - Postpartum Hemorrhage
Phase 3RecruitingStony Brook University13582025-01-272025-05-04
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women at Higher Risk
Tranexamic acid, Placebo - Postpartum Hemorrhage
Phase 3RecruitingLondon School of Hygiene and Tropical Medicine400002024-04-222026-11-04
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
Tranexamic Acid / Sodium chloride - Postpartum Hemorrhage
Phase 3RecruitingUniversity Hospital, Bordeaux13802020-08-072025-02-10

Narrower conditions

Postpartum Hemorrhage (5)  ·  Depression, Postpartum (2)  ·  Depression (1)  ·  Familial Primary Pulmonary Hypertension (1)  ·  Hemorrhage (1)  ·  Placenta Previa (1)  ·  Pre-Eclampsia (1)  ·  Pulmonary Embolism (1)  ·  Thrombophilia (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (7)  ·  Pregnancy Complications (7)  ·  Urogenital Diseases (7)  ·  Obstetric Labor Complications (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Uterine Hemorrhage (5)  ·  Hemorrhage (4)  ·  Depressive Disorder (2)  ·  Lung Diseases (2)  ·  Mental Disorders (2)  ·  Mood Disorders (2)  ·  Respiratory Tract Diseases (2)  ·  Behavior (1)

Interventions

Sodium Chloride (2)  ·  Tranexamic Acid (2)  ·  Aspirin (1)  ·  Dalteparin (1)  ·  Enoxaparin (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Nadroparin (1)  ·  Oxytocin (1)  ·  Tinzaparin (1)  ·  brexanolone (1)

Sponsors

Lipocine Inc. (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Nanjing Minova Pharmaceutical Co., Ltd. (1)  ·  ResQ Medical Ltd (1)  ·  Stony Brook University (1)  ·  University Hospital, Bordeaux (1)  ·  University of Calgary (1)

Countries

United States (3)  ·  France (2)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Ireland (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Tanzania (1)

Top investigators

Judith Lieber (1)  ·  Leslie Skeith, MD (1)  ·  Marc Rodger, MD (1)  ·  Scott Chudnoff, MD (1)

Results publications

PMID 39162220, PMID 38044460, PMID 40448004